Clinical Trials Directory

Trials / Sponsors / RHEACELL GmbH & Co. KG

RHEACELL GmbH & Co. KG

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingAllogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
Venous Leg Ulcer
Phase 32024-12-26
Active Not RecruitingAllogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
Epidermolysis Bullosa
Phase 32023-10-18
Active Not RecruitingAllogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III,
Epidermolysis Bullosa
Phase 32023-06-13
CompletedAllogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Skin Ulcer Venous Stasis Chronic
Phase 22021-08-18
UnknownAllogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
Limbal Stem Cell Deficiency
Phase 1 / Phase 22019-07-04
TerminatedAllogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
Acute-On-Chronic Liver Failure
Phase 1 / Phase 22019-03-22
CompletedAllogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
Recessive Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 22019-02-16
TerminatedAllogeneic ABCB5-positive Stem Cells for Treatment of PAOD
Peripheral Arterial Occlusive Disease
Phase 1 / Phase 22018-03-05
CompletedAllogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"
Diabetic Neuropathic Ulcer
Phase 1 / Phase 22017-11-21
CompletedAllogeneic ABCB5-positive Stem Cells for Treatment of CVU
Skin Ulcer Venous Stasis Chronic
Phase 1 / Phase 22017-11-16
TerminatedClinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating F
Skin Ulcer Venous Stasis Chronic
Phase 1 / Phase 22016-08-01